Counter to this notion, we found that GRO-α (CXCL1) levels were markedly raised in ET patients compared to other MPNs, while EGF and eotaxin (CCL11) were higher in both ET and PV compared to MF patients (Fig. 2A). This evidence concerns the gene CXCL1 and acquired polycythemia vera.